GE HealthCare Technologies's EBIT per Share for the
three
months ended in Mar. 2026 was MXN23.75.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was MXN120.27.
During the past 12 months, the average EBIT per Share Growth Rate of GE HealthCare Technologies was -2.00% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 2.80% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -0.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for GE HealthCare Technologies's EBIT per Share or its related term are showing as below:
MEX:GEHC'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -3.9 Med: 0.2 Max: 5.9
Current: 2.8
During the past 7 years, the highest 3-Year average EBIT per Share Growth Rate of GE HealthCare Technologies was 5.90% per year. The lowest was -3.90% per year. And the median was 0.20% per year.
MEX:GEHC's 3-Year EBIT Growth Rate is ranked worse than 59.13% of 690
companies
in the Medical Devices & Instruments industry
Industry Median: 9.5
vs MEX:GEHC: 2.80
GE HealthCare Technologies (MEX:GEHC) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
GE HealthCare Technologies EBIT per Share Related Terms
GE HealthCare Technologies EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN120.27
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GE HealthCare Technologies (MEX:GEHC) has a EBIT per Share of MXN120.27 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on GE HealthCare Technologies and its competitors. According to the industry distribution chart, GE HealthCare Technologies ranks #408 out of 690 companies in the Medical Devices & Instruments industry, placing it in the top 59.1%.
Is GE HealthCare Technologies' EBIT per Share too high?
GE HealthCare Technologies' current EBIT per Share is MXN120.27. Based on the distribution chart, GE HealthCare Technologies ranks #408 out of 690 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, GE HealthCare Technologies has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GE HealthCare Technologies' EBIT per Share compare to DXCM and STE?
According to the Medical Devices & Instruments industry distribution chart, GE HealthCare Technologies ranks #408 out of 690 companies for EBIT per Share. This places GE HealthCare Technologies in the lower half of its industry. The industry median EBIT per Share is 9.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.50, based on 690 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on GE HealthCare Technologies and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GE HealthCare Technologies's current EBIT per Share is MXN120.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GE HealthCare Technologies stock overvalued right now?
Based on GuruFocus' analysis, GE HealthCare Technologies (MEX:GEHC) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN1,493.20, compared to a current price of MXN1,149.89 — trading 23% below its estimated fair value. The current EBIT per Share is MXN120.27. GE HealthCare Technologies' overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For GE HealthCare Technologies (MEX:GEHC), the current EBIT per Share is MXN120.27 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GE HealthCare Technologies (MEX:GEHC) Overvalued in 2026?
Based on GuruFocus' analysis, GE HealthCare Technologies stock appears to be undervalued.
The current stock price of MXN1,149.89 is trading 23% below its estimated GF Value™ of MXN1,493.20.
GuruFocus considers GE HealthCare Technologies to be Modestly Undervalued.
Key valuation signals for MEX:GEHC:
EBIT per Share: MXN120.27
GF Value™: MXN1,493.20 vs. price of MXN1,149.89 (23% below fair value)
No single metric tells the full story. See the MEX:GEHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
63GF Score
Get the complete analysis for MEX:GEHC
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:GEHC has been successfully added to your 
